Population
Untreated patients with small cell carcinoma of the lung, categorized into limited disease and extensive…
Design
Cohort
Authors
Loading...
Fibrinogen may track SCCL activity and chemotherapy response; leaves open whether peripheral fibrinolytic markers reflect tumor-site activity.
Peripheral blood measurements of fibrinolytic markers do not correlate with the action of the fibrinolytic system at tumor sites in patients with small cell carcinoma of the lung.
Takeshi Wajima (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: